Cargando…

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application

Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Susidarti, Ratna Asmah, Utomo, Rohmad Yudi, Qodria, Lailatul, Ramadani, Ratna Dwi, Ohta, Youichiro, Hattori, Yoshihide, Kirihata, Mitsunori, Meiyanto, Edy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714113/ https://www.ncbi.nlm.nih.gov/pubmed/31516505 http://dx.doi.org/10.4103/1735-5362.263552

Ejemplares similares

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells
por: Hermawan, Adam, et al.
Publicado: (2023)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells
por: Handayani, Sri, et al.
Publicado: (2022)

Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Two Active Compounds from Caesalpinia sappan L. in Combination with Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest on WiDr Cells
por: Handayani, Sri, et al.
Publicado: (2017)

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
por: Hattori, Yoshihide, et al.
Publicado: (2017)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2018)

Aptamers for Addressed Boron Delivery in BNCT: Effect of Boron Cluster Attachment Site on Functional Activity
por: Novopashina, Darya S., et al.
Publicado: (2022)

CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti-Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells
por: Novitasari, Dhania, et al.
Publicado: (2021)

Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography
por: Balcerzyk, Marcin, et al.
Publicado: (2020)

Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT
por: Tsurubuchi, Takao, et al.
Publicado: (2020)

Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT
por: Novopashina, Darya Sergeevna, et al.
Publicado: (2021)

Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023)

Correcting for the heterogeneous boron distribution in a tumor for BNCT dose calculation
por: Teng, Yi-Chiao, et al.
Publicado: (2023)

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies
por: Monti Hughes, Andrea, et al.
Publicado: (2023)

Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT
por: Seneviratne, Danushka S., et al.
Publicado: (2023)

Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a Monte Carlo study
por: Jung, Joo-Young, et al.
Publicado: (2017)

Development of MRI-Detectable Boron-Containing Gold Nanoparticle-Encapsulated Biodegradable Polymeric Matrix for Boron Neutron Capture Therapy (BNCT)
por: Wu, Chun-Yi, et al.
Publicado: (2021)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

Antibody-Based Receptor Targeting Using an Fc-Binding Peptide-Dodecaborate Conjugate and Macropinocytosis Induction for Boron Neutron Capture Therapy
por: Nakase, Ikuhiko, et al.
Publicado: (2020)

Imaging and profiling of absorbed doses in thermal neutron fields for Boron Neutron Capture Therapy (BNCT)
por: Gambarini, G, et al.
Publicado: (1999)

Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
por: Hiratsuka, Junichi, et al.
Publicado: (2020)

Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy
por: Laird, Mathilde, et al.
Publicado: (2023)

RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019)

A new detector concept based on the prompt gamma radiation analysis for In vivo boron monitoring in BNCT
por: Silarski, M, et al.
Publicado: (2023)

In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection
por: Marforio, Tainah Dorina, et al.
Publicado: (2023)

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2016)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

PET-based approach to treatment planning systems : an improvement toward successful Boron Neutron Capture Therapy (BNCT)
por: Daquino, Giuseppe G
Publicado: (2003)

TB-03 THE SURVIVAL PROLONGATION EFFECT OF NOVEL BORON COMPOUND FOR BNCT USING RAT BRAIN TUMOR MODEL
por: Fukuo, Yusuke, et al.
Publicado: (2019)

Boron Delivery to Brain Cells via Cerebrospinal Fluid (CSF) Circulation for BNCT in a Rat Melanoma Model
por: Kusaka, Sachie, et al.
Publicado: (2022)

Diastereoselective Synthesis of the Borylated d-Galactose Monosaccharide 3-Boronic-3-Deoxy-d-Galactose and Biological Evaluation in Glycosidase Inhibition and in Cancer for Boron Neutron Capture Therapy (BNCT)
por: Simone, Michela I.
Publicado: (2023)

Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner
por: Jenie, Riris Istighfari, et al.
Publicado: (2019)

A New Diterpenoid of Indonesian Scoparia dulcis Linn: Isolation and Cytotoxic Activity against MCF-7 and T47D Cell Lines
por: Hasnawati, Hasnawati, et al.
Publicado: (2023)

Cobaltabis(dicarbollide) ([o-COSAN](−)) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma
por: Nuez-Martinez, Miquel, et al.
Publicado: (2021)

Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer
por: Seneviratne, Danushka, et al.
Publicado: (2022)

Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Prevention and early management of carotid blowout syndrome for patients receiving head and neck salvage boron neutron capture therapy (BNCT)
por: Lan, Tien-Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lts01l0f1kjnk00p6i36nmeoip